Licensing

Accompanying the direct purchase of finished key components from Bioprocess International is an implicit license to use the recombinant source material within the context of an immunoassay of the purchaser's own design ("Licensed Diagnostic Product").

The royalty for this usage right has been integrated into the final purchase price of each ordered recombinant polypeptide. Should, however, a client express an interest in reaching a more comprehensive licensing agreement which entitles the licensee to manufacture, in-house, the source ingredient(s), then running royalties on final sales do become due, in addition to a negotiated upfront down-payment.

Due to restrictions in export regulations and/or company policy, the latter type agreement may not always be possible. In principle, however, both approaches are conceivable and have already resulted in several issued licenses pertaining to Bioprocess technologies, each designed to best suit a client’s needs.